Nexalin Technology (NXL) Non Operating Income (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Non Operating Income of $23065.0 for Q1 2026, down 3.64% year-over-year from $23936.0 in Q1 2025, and down 37.02% quarter-over-quarter from $36621.0 in Q4 2025.
Nexalin Technology (NXL) Non Operating Income (2021 - 2026) Analysis & Trends
Nexalin Technology's Non Operating Income history runs 6 years deep, the most recent figure standing at $23065.0 for Q1 2026.
- In Q1 2026, Non Operating Income fell 3.64% year-over-year to $23065.0; the TTM figure through Mar 2026 stood at $168877.0 (up 20.82% YoY), while the FY2025 annual figure was $169748.0, up 19.03% from the prior year.
- Non Operating Income for Q1 2026 stood at $23065.0, down from $36621.0 in the prior quarter.
- The five-year high for Non Operating Income was $843804.0 in Q4 2023, with the low at -$18132.0 in Q1 2022.
- The 5-year median for Non Operating Income is $36621.0 (2025), against an average of $87959.5.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income surged 8487.71% in 2023, then tumbled 95.03% in 2024.
- Nexalin Technology's Non Operating Income stood at -$10060.0 in 2022, then soared by 8487.71% to $843804.0 in 2023, then sank by 95.03% to $41921.0 in 2024, then retreated by 12.64% to $36621.0 in 2025, then sank by 37.02% to $23065.0 in 2026.
- Business Quant data shows NXL's Non Operating Income at $23065.0 in Q1 2026, $36621.0 in Q4 2025, and $69320.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | - |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | - |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | 8,145.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,145.00 |
| Mar 31, 2026 | 23,065.00 |
| Dec 31, 2025 | 36,621.00 |
| Sep 30, 2025 | 69,320.00 |
| Jun 30, 2025 | 39,871.00 |
| Mar 31, 2025 | 23,936.00 |
| Dec 31, 2024 | 41,921.00 |
| Sep 30, 2024 | 60,101.00 |
| Jun 30, 2024 | 13,819.00 |
| Mar 31, 2024 | 26,772.00 |
| Dec 31, 2023 | 843,804.00 |
| Sep 30, 2023 | 118,348.00 |
| Jun 30, 2023 | 54,423.00 |
| Mar 31, 2023 | 31,012.00 |
| Dec 31, 2022 | -10,060.00 |
| Sep 30, 2022 | 157,793.00 |
| Jun 30, 2022 | -17,302.00 |
| Mar 31, 2022 | -18,132.00 |
| Dec 31, 2021 | -18,439.00 |
| Sep 30, 2021 | -4,259.00 |